List view / Grid view

U.S. Food and Drug Administration (FDA)

 

news

FDA approves Merck’s head and neck cancer drug

8 August 2016 | By Merck

Under the FDA’s accelerated approval regulations, Keytruda, a humanized monoclonal antibody that works by increasing the ability of the body’s immune system to help detect and fight tumour cells, is approved based on tumour response rate and durability of response. However, continued approval for the drug may be contingent upon…